Amiodarone-induced acute lung toxicity in an ICU setting
- 1 April 2005
- journal article
- case report
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 49 (4), 569-571
- https://doi.org/10.1111/j.1399-6576.2005.00606.x
Abstract
Amiodarone is a highly effective antiarrhythmic drug, albeit notorious for its serious pulmonary toxicity. The incidence of amiodarone-induced pulmonary toxicity (APT) appears to be 1% per year (1). We report a case of very acute APT in a man suffering from postoperative atrial fibrillation.Keywords
This publication has 15 references indexed in Scilit:
- Cardiac complications after noncardiac thoracic surgery: an evidence-based current reviewThe Annals of Thoracic Surgery, 2003
- Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone*Chest, 2003
- Acute amiodarone-induced pulmonary toxicity after lung operationThe Annals of Thoracic Surgery, 2002
- Acute pulmonary toxicity after low-dose amiodarone therapyThe Annals of Thoracic Surgery, 2001
- Is Amiodarone an Underrecognized Cause of Acute Respiratory Failure in the ICU?Chest, 2001
- Amiodarone‐induced adult respiratory distress syndrome after nonthoracotomy subcutaneous defibrillator implantationJournal of Internal Medicine, 2001
- Intravenous amiodarone in intensive careIntensive Care Medicine, 2000
- Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trialsThe Lancet, 1997
- Amiodarone pulmonary toxicityBMJ, 1997
- Amiodarone and the Development of ARDS After Lung SurgeryChest, 1994